Called by Psycho as the “Superstar High Jumper of the Week”, the penny stock of QuantRX Biomedical Corp. (OTC: QTXB) did exactly that – jump. Peaking within 2 minutes of trading today at 0.139, QTXB stock took less than 3 minutes to jump off of that cliff, plunging more than -46% with 5 minutes of the peak. While novice traders continue to be sucked into the Darth Trader trap of Psycho’s PPC beam, perhaps the money raised today by the insiders selling might be enough to get the biotech’s website back up and running to prove their patented PadKit technology for the worldwide healthcare industry is worth a crap.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
QTXB Stock Quote
Market Cap: 4.41M
Last: 0.066 ▲ 0.048 (+266.67%)
Dollar Volume: $185,918
Issued and Outstanding: 52,528,644
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
The first quote from Psycho’s alert on QuantRX Biomedical today was “QTXB is so small, and so ready to fly, I would be shocked if we didn’t see a triple digit move today!” That’s really not so hard to do when the stock gaps open at 0.09 from yesterday’s close of 0.018.
QuantRX has developed a technology platform for use in the, you guessed it, healthcare industry. These platforms include: inSync®, Unique™, PadKit®, and OEM branded OTC and laboratory testing products based on the Company’s core intellectual property related to its PAD technology.
Go figure the irony too: Those involved with the bags left over by buying QTXB stock off of the Psycho’s alert can actually use this technology QuantRX has developed. The products their platfrm is design for are intended for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs.
If you don’t have hemorrhoids after being mugged by buying into QTXB stock, consider yourself a lucky one cause it’s gonna get much, much worse as the day goes on.
About QTXB Stock
QuantRX Biomedical Corp. is focused on the medical equipment industry after developing, with plan to commercialize, its patented PadKit® technology for the worldwide healthcare industry.
Last 5 Trading Sessions:
I doubt one single trader not involved with the “behind the scenes” workings of Psycho makes even half the amount QuantRX Biomedical Corp. reported as revenues last quarter: $3,341. For those still chasing the penny stock picks coming out of the once insanely awesome promotions offered by Psycho, like Tony said to Elvira: “Looking good, honey. Keep up the bad work.”
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)Share